UBS ASSET MANAGEMENT AMERICAS LLC - IMPAX LABORATORIES INC ownership

IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101. A total of 2 filers reported holding IMPAX LABORATORIES INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS ASSET MANAGEMENT AMERICAS LLC ownership history of IMPAX LABORATORIES INC
ValueSharesWeighting
Q1 2018$866,634,000
+54.6%
44,557
+32.4%
0.00%
Q4 2017$560,539,000
-18.0%
33,6660.0%0.00%
-100.0%
Q3 2017$683,419,000
+28.0%
33,666
+1.5%
0.00%0.0%
Q2 2017$533,860,000
+9.6%
33,159
-13.9%
0.00%
Q1 2017$487,127,000
+238687.7%
38,508
+149.8%
0.00%
Q4 2016$204,000
-99.2%
15,416
-98.5%
0.00%
-100.0%
Q3 2016$24,426,000
-40.3%
1,030,579
-27.5%
0.03%
-43.5%
Q2 2016$40,943,000
-14.0%
1,420,630
-4.5%
0.05%
-16.4%
Q1 2016$47,611,000
-39.1%
1,486,880
-18.7%
0.06%
-38.2%
Q4 2015$78,174,000
+25.4%
1,828,215
+3.2%
0.09%
+29.0%
Q3 2015$62,357,000
-23.0%
1,771,009
+0.5%
0.07%
-10.4%
Q2 2015$80,932,000
-14.6%
1,762,461
-12.8%
0.08%
-15.4%
Q1 2015$94,767,000
+42.3%
2,021,931
-3.8%
0.09%
+44.4%
Q4 2014$66,607,000
+25.8%
2,102,479
-5.8%
0.06%
+21.2%
Q3 2014$52,931,000
-19.5%
2,232,414
+1.8%
0.05%
-21.2%
Q2 2014$65,753,000
+8.4%
2,192,509
-4.5%
0.07%
+1.5%
Q1 2014$60,676,000
+5.5%
2,296,618
+0.4%
0.06%
-1.5%
Q4 2013$57,515,000
+33.1%
2,287,838
+8.6%
0.07%
+24.5%
Q3 2013$43,221,000
+0.3%
2,107,324
-2.4%
0.05%
-5.4%
Q2 2013$43,073,0002,159,0590.06%
Other shareholders
IMPAX LABORATORIES INC shareholders Q2 2018
NameSharesValueWeighting ↓
Aravt Global 2,670,000$125,143,0009.40%
Krensavage Asset Management, LLC 410,944$19,261,0008.77%
BANBURY PARTNERS LLC 292,660$13,717,0008.70%
Slate Path Capital LP 1,935,000$90,693,0005.72%
BLUE JAY CAPITAL MANAGEMENT, LLC 285,000$13,358,0004.69%
Orbimed Advisors 6,678,000$312,998,0002.67%
Pennant Capital Management, LLC 2,025,000$94,912,0001.78%
Iguana Healthcare Management, LLC 75,000$3,515,0001.48%
Leonard Capital Management, Inc. 89,235$4,182,0001.44%
HUSSMAN STRATEGIC ADVISORS, INC. 250,000$11,718,0001.23%
View complete list of IMPAX LABORATORIES INC shareholders